Abrupt Discontinuation of Alprazolam and Cognitive Style in Patients With Panic Disorder
- 1 October 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Psychopharmacology
- Vol. 26 (5), 519-523
- https://doi.org/10.1097/01.jcp.0000236653.85791.60
Abstract
The objective of this study was to ascertain the relationship of alprazolam plasma levels and an anxiety-prone cognitive style to the characteristics and severity of early withdrawal after abrupt discontinuation of alprazolam in 26 patients with panic disorder. After 8 and 9 weeks of fixed-dose treatment, patients were hospitalized for 24 hours. On 1 admission, ordered at random, treatment was maintained; on the other, placebo was substituted double blind. The Anxious Thoughts and Tendencies questionnaire was administered before treatment. Alprazolam plasma levels were measured 7 times on the day after each admission. Before each blood sampling, the Profile of Mood States and performance tasks were administered, and vital signs were recorded. On the day after abrupt discontinuation of alprazolam, Profile of Mood States anxiety, depression, fatigue, and confusion increased; vigor and elation decreased; speed on the digit symbol substitution task improved; and systolic blood pressure increased substantially over time. High Anxious Thoughts and Tendencies scores were related specifically to more anxiety. Our findings (1) confirm that dysphoric mood, fatigue, low energy, confusion, and elevated systolic blood pressure are part of the early syndrome of withdrawal from alprazolam in patients with panic disorder, notably as the drop in plasma levels approaches 50%; (2) indicate a psychomotor deficit persisting beyond dose stabilization; (3) suggest that an anxiety-prone cognitive style measurable before undertaking treatment may be a risk factor for more severe anxiety upon discontinuation; and (4) provide a rationale for applying cognitive behavior therapy during benzodiazepine taper.This publication has 19 references indexed in Scilit:
- Are Benzodiazepines Still the Medication of Choice for Patients With Panic Disorder With or Without Agoraphobia?American Journal of Psychiatry, 2003
- Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorderPsychological Medicine, 2003
- A general anxiety-prone cognitive style in anxiety disordersJournal of Affective Disorders, 2001
- Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic DisorderJAMA, 2000
- Cognitive–behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: A long-term follow-up of the Peoria and Dartmouth studies.Journal of Consulting and Clinical Psychology, 1999
- Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical managementActa Psychiatrica Scandinavica, 1998
- Discontinuation of benzodiazepine treatment: efficacy of cognitive- behavioral therapy for patients with panic disorderAmerican Journal of Psychiatry, 1993
- GRADUAL WITHDRAWAL OF DIAZEPAM AFTER LONG-TERM THERAPYThe Lancet, 1983
- Withdrawal from long-term benzodiazepine treatment.BMJ, 1981
- LENGTH OF TREATMENT WITH ANXIOLYTIC SEDATIVES AND RESPONSE TO THEIR SUDDEN WITHDRAWALActa Psychiatrica Scandinavica, 1973